Konstantinos N Syrigos Selected Research

Konstantinos N Syrigos Research Topics

Disease

61	Neoplasms (Cancer) 03/2024 - 05/2002
21	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2023 - 09/2005
13	Pancreatic Neoplasms (Pancreatic Cancer) 07/2014 - 05/2003
12	Lung Neoplasms (Lung Cancer) 03/2024 - 07/2006
11	Neoplasm Metastasis (Metastasis) 05/2017 - 05/2002
10	COVID-19 12/2023 - 01/2021
6	Adenocarcinoma 10/2016 - 09/2002
5	Breast Neoplasms (Breast Cancer) 12/2021 - 04/2010
5	Colorectal Neoplasms (Colorectal Cancer) 05/2018 - 05/2002
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 08/2015 - 07/2006
5	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 03/2014 - 03/2010
4	Melanoma (Melanoma, Malignant) 12/2022 - 05/2005
4	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 09/2002
4	Adenocarcinoma of Lung 01/2020 - 01/2009
3	Carcinogenesis 03/2024 - 03/2011
3	Infections 01/2023 - 09/2017
3	Disease Progression 09/2014 - 09/2008
3	Head and Neck Neoplasms (Head and Neck Cancer) 04/2014 - 09/2010
3	Carcinoma (Carcinomatosis) 03/2014 - 05/2013
3	Stomach Neoplasms (Stomach Cancer) 02/2003 - 07/2002
2	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 02/2019
2	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 01/2002
2	Hemorrhage 01/2021 - 02/2019
2	Thrombocytopenia (Thrombopenia) 02/2019 - 12/2016
2	Circulating Neoplastic Cells 11/2016 - 03/2013
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2016 - 03/2014
2	Urinary Bladder Neoplasms (Bladder Cancer) 07/2015 - 03/2003
2	Weight Loss (Weight Reduction) 01/2015 - 09/2008
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2023
1	Respiratory Insufficiency (Respiratory Failure) 01/2023
1	Rheumatoid Arthritis 01/2023
1	Sepsis (Septicemia) 01/2023
1	Takotsubo Cardiomyopathy 01/2023
1	Pneumonia (Pneumonitis) 01/2023
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023

Drug/Important Bio-Agent (IBA)

14	Biomarkers (Surrogate Marker)IBA 03/2022 - 03/2003
13	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2002
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2016 - 05/2002
8	Gemcitabine FDA Link 07/2014 - 09/2005
6	PlatinumIBA 03/2016 - 09/2005
5	Tyrosine Kinase InhibitorsIBA 09/2022 - 05/2013
5	Docetaxel (Taxotere)FDA Link 03/2016 - 09/2005
5	EnzymesIBA 05/2003 - 05/2002
5	ImmunosorbentsIBA 05/2003 - 05/2002
4	Monoclonal AntibodiesIBA 05/2023 - 03/2011
4	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2018
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2022 - 03/2011
4	ErbB Receptors (EGF Receptor)IBA 06/2021 - 07/2008
4	B7-H1 AntigenIBA 05/2021 - 01/2014
3	AntibodiesIBA 01/2023 - 04/2010
3	Messenger RNA (mRNA)IBA 05/2021 - 08/2012
3	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 09/2014 - 02/2003
3	CytokinesIBA 09/2008 - 05/2002
3	Diphosphonates (Bisphosphonates)IBA 01/2008 - 09/2002
2	Tumor Biomarkers (Tumor Markers)IBA 03/2024 - 02/2003
2	Phosphotransferases (Kinase)IBA 03/2024 - 09/2017
2	Immunoconjugates (Immunoconjugate)IBA 02/2023 - 03/2011
2	VaccinesIBA 01/2023 - 09/2021
2	Paclitaxel (Taxol)FDA LinkGeneric 02/2022 - 04/2012
2	MicroRNAs (MicroRNA)IBA 01/2022 - 11/2016
2	Neurotransmitter Agents (Neurotransmitter)IBA 10/2021 - 04/2021
2	Capecitabine (Xeloda)FDA Link 05/2018 - 01/2016
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 10/2016 - 05/2013
2	RamucirumabIBA 03/2016 - 08/2014
2	Temozolomide (Temodar)FDA LinkGeneric 01/2016 - 03/2010
2	taxaneIBA 08/2015 - 07/2010
2	Analgesics (Analgesic Drugs)IBA 01/2015 - 09/2002
2	MucinsIBA 03/2013 - 03/2011
2	Connective Tissue Growth FactorIBA 03/2013 - 03/2011
2	Antineoplastic Agents (Antineoplastics)IBA 09/2012 - 01/2006
2	Carboplatin (JM8)FDA LinkGeneric 04/2012 - 01/2010
2	Sunitinib (Sutent)FDA Link 03/2011 - 03/2010
2	Everolimus FDA Link 03/2011 - 03/2010
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 03/2010 - 10/2007
2	TOR Serine-Threonine KinasesIBA 03/2010 - 06/2009
2	Ibandronic Acid (Boniva)FDA Link 07/2006 - 09/2002
1	Checkpoint Kinase 1IBA 03/2024
1	tocilizumab (atlizumab)FDA Link 05/2023
1	interleukin-6 receptor alphaIBA 05/2023
1	trastuzumab deruxtecanIBA 02/2023
1	Interferon-gamma (Interferon, gamma)IBA 01/2023
1	C-Reactive ProteinIBA 01/2023
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	Urokinase Plasminogen Activator ReceptorsIBA 01/2023
1	TNF-Related Apoptosis-Inducing LigandIBA 01/2023
1	Programmed Cell Death 1 ReceptorIBA 12/2022
1	osimertinibIBA 09/2022
1	Untranslated RNA (Noncoding RNA)IBA 01/2022

Therapy/Procedure

26	Drug Therapy (Chemotherapy) 01/2020 - 01/2006
23	Therapeutics 12/2023 - 09/2005
7	Radiotherapy 01/2021 - 01/2006
6	Immunotherapy 01/2023 - 01/2019
2	Secondary Prevention 11/2017 - 05/2005
2	Combined Modality Therapy 01/2015 - 04/2014
2	Pancreaticoduodenectomy 03/2014 - 03/2013
2	Combination Drug Therapy (Combination Chemotherapy) 09/2009 - 09/2005
2	Intravenous Infusions 01/2008 - 07/2006
1	Precision Medicine 03/2024
1	Immunomodulation 05/2023